Arch Biopartners Closes Private Placement, Raises $600,000 for Research and Working Capital

Arch Biopartners Inc. has successfully closed a non-brokered private placement, raising $600,000 CAD for the company. The private placement involved the issuance of 400,000 common shares priced at $1.50 per share. The net proceeds from the offering will be utilized by Arch as general working capital and to cover certain research expenses that are not…

Read More

Zonetail Provides Update on Relisting and Marketing Consultant Appointment

Zonetail Inc. has recently provided an update on the relisting of its common shares on the TSX Venture Exchange (the ‘Exchange’). After a delay in filing its annual financial statements, the Ontario Securities Commission (OSC) issued a failure-to-file cease trade order against the company. However, the order was revoked on June 28, 2024, after Zonetail…

Read More

Supreme Court Ruling on Federal Agency Power Sparks Conservative Strategizing

Conservatives and corporate lobbyists have begun strategizing after the Supreme Court limited the power of federal agencies in a landmark decision. The ruling invalidated the decades-old legal precedent known as Chevron deference, which required federal judges to defer to regulatory agencies in cases where the law is ambiguous or Congress fails to specify its intentions….

Read More

Scott+Scott Investigates Potential Breach of Fiduciary Duties by Globe Life Leadership

Scott+Scott Attorneys at Law LLP, an international securities and consumer rights litigation firm, is conducting an investigation into whether the leadership of Globe Life Inc. breached their fiduciary duties to Globe Life and its shareholders. The firm is specifically looking into whether members of Globe Life’s board of directors or senior management failed to manage…

Read More

“A Quiet Place: Day One” Earns $53 Million in Opening Weekend, “Inside Out 2” Tops Box Office

“A Quiet Place: Day One,” the prequel to the popular horror franchise, has made a strong debut at the box office, earning an estimated $53 million in its opening weekend in North American theaters. This figure surpasses expectations and marks the highest opening for the franchise. The film stars Lupita Nyong’o and Joseph Quinn and…

Read More